Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,367,980
-$6,448,472 QoQ
Shares Held
602,013
-43.9% QoQ
Ownership
0.987%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. JANX ranks #148 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in JANX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,367,980 | 602,013 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,816,452 | 1,073,656 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $16,010,838 | 655,108 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,050,118 | 348,490 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,729,506 | 286,278 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $20,363,777 | 380,347 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $14,343,841 | 315,735 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,438,309 | 344,672 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,070,987 | 347,171 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $428,642 | 39,948 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $146,603 | 14,544 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $269,674 | 22,719 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $192,321 | 14,603 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $190,196 | 14,047 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $193,699 | 15,864 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $257,173 | 17,934 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $290,978 | 14,748 | Shares | Defined | 2022-02-17 | |
| 2021-06-30 | $1,721,550 | 69,000 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||